Search Results 101-110 of 17467 for cannabis
Patient is unwilling to abstain from using recreational or medicinal cannabis, or synthetic cannabinoid-based medications (including Sativex) during the study.
Positive toxicology screen for cannabis and cannabis use disorder by structured clinical interview. Participants who use cannabis for recreational or ...
... cannabis on a case-by-case basis. History of drug use disorder over the past year, other than alcohol/nicotine/caffeine/cannabis. Plans to travel across ...
Is currently using recreational or medicinal cannabis, or synthetic cannabinoid based medications (including Sativex®) other than the investigational ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Cariprazine; Carisoprodol; Carphenazine; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine ...
History of marijuana/cannabis use (amount/ times per week). Excessive tobacco use (i.e. more than 10 cigarettes a day). Excessive alcohol (> 5 drinks daily ...
Currently or in the past used recreational or medicinal cannabis, or synthetic cannabinoid based medications (including Sativex®) within the three months ...
Cannabis; Carbamazepine; Carbidopa; Carbinoxamine; Carisoprodol; Ceritinib; Cetirizine; Chloral Hydrate; Chlordiazepoxide; Chlorpromazine; Chlorzoxazone ...
* Current use of any cannabis product or cannabidiol that is not in oral solution/capsule/tablet form, not obtained from a government-approved dispensary ...
Patients with substance misuse issues (e.g., smoking or other consumption of tobacco/cannabis, and alcohol dependency),. 3. Closed head injury with resultant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.